US6673335B1
(en)
*
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
BR9307141A
(pt)
*
|
1992-09-29 |
1999-03-30 |
Inhale Therapeutic Syst |
Processo para a liberação sistência pulsátil de um fragmento ativo de hormônio de paratiróide (PTH) para um hospedeiro mamífero e para um paciente e composição farmacêutica
|
US7448375B2
(en)
*
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
US6051256A
(en)
*
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
ATE264096T1
(de)
|
1994-03-07 |
2004-04-15 |
Nektar Therapeutics |
Verfahren und mittel zur verabreichung von insulin über die lunge
|
AU696387B2
(en)
*
|
1994-05-18 |
1998-09-10 |
Inhale Therapeutic Systems, Inc. |
Methods and compositions for the dry powder formulation of interferons
|
US6165976A
(en)
*
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
ATE238043T1
(de)
|
1994-12-22 |
2003-05-15 |
Astrazeneca Ab |
Parathyroidhormon pth enthaltende therapeutische zubereitung zur inhalation
|
MY131733A
(en)
|
1994-12-22 |
2007-08-30 |
Astra Ab |
Aerosol drug formulations
|
US6165463A
(en)
*
|
1997-10-16 |
2000-12-26 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
US6019968A
(en)
*
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
US6309671B1
(en)
|
1995-04-14 |
2001-10-30 |
Inhale Therapeutic Systems |
Stable glassy state powder formulations
|
US6258341B1
(en)
|
1995-04-14 |
2001-07-10 |
Inhale Therapeutic Systems, Inc. |
Stable glassy state powder formulations
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
GB9515182D0
(en)
*
|
1995-07-24 |
1995-09-20 |
Co Ordinated Drug Dev |
Improvements in and relating to powders for use in dry powder inhalers
|
ATE212220T1
(de)
|
1996-01-24 |
2002-02-15 |
Byk Gulden Lomberg Chem Fab |
Verfahren zur herstellung von pulverförmigen lungensurfactant-zubereitungen
|
US6503480B1
(en)
*
|
1997-05-23 |
2003-01-07 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US6254854B1
(en)
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
US20030203036A1
(en)
*
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
KR20010022007A
(ko)
*
|
1997-07-18 |
2001-03-15 |
추후보정 |
생물학적 활성 물질의 서방용 생분해성 마크로머
|
US6309623B1
(en)
*
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6541606B2
(en)
|
1997-12-31 |
2003-04-01 |
Altus Biologics Inc. |
Stabilized protein crystals formulations containing them and methods of making them
|
WO1999055310A1
(en)
|
1998-04-27 |
1999-11-04 |
Altus Biologics Inc. |
Stabilized protein crystals, formulations containing them and methods of making them
|
TW581681B
(en)
|
1998-02-20 |
2004-04-01 |
Nektar Therapeutics |
Liquid crystal forms of cyclosporin
|
WO1999055362A1
(en)
*
|
1998-04-29 |
1999-11-04 |
Genentech, Inc. |
Spray dried formulations of igf-i
|
US6284282B1
(en)
|
1998-04-29 |
2001-09-04 |
Genentech, Inc. |
Method of spray freeze drying proteins for pharmaceutical administration
|
GB9810559D0
(en)
*
|
1998-05-15 |
1998-07-15 |
Bradford Particle Design Ltd |
Method and apparatus for particle formation
|
US6451349B1
(en)
*
|
1998-08-19 |
2002-09-17 |
Quadrant Healthcare (Uk) Limited |
Spray-drying process for the preparation of microparticles
|
US6956021B1
(en)
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
US20070212422A1
(en)
*
|
1999-11-10 |
2007-09-13 |
Manfred Keller |
Dry powder for inhalation
|
DE60026982T2
(de)
*
|
1999-04-05 |
2006-11-16 |
Mannkind Corp., Danbury |
Verfahren zur bildung von feinem pulver
|
WO2000061178A1
(en)
*
|
1999-04-13 |
2000-10-19 |
Inhale Therapeutics Systems, Inc. |
Pulmonary administration of dry powder formulations for treating infertility
|
US7112341B1
(en)
|
1999-04-13 |
2006-09-26 |
Nektar Therapeutics |
Pulmonary administration of dry powder formulations for treating infertility
|
JP4874483B2
(ja)
|
1999-06-09 |
2012-02-15 |
ロバート イー. シーバース |
超臨界流体補助ネブライゼーション及びバブル乾燥
|
US6858199B1
(en)
|
2000-06-09 |
2005-02-22 |
Advanced Inhalation Research, Inc. |
High efficient delivery of a large therapeutic mass aerosol
|
WO2001000654A2
(en)
*
|
1999-06-29 |
2001-01-04 |
Pharmaceutical Discovery Corporation |
Purification and stabilization of peptide and proteins in pharmaceutical agents
|
US9006175B2
(en)
*
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
MXPA01013168A
(es)
*
|
1999-06-30 |
2002-07-30 |
Inhale Therapeutic Syst |
Proceso de secado por rocio para preparar polvos secos.
|
EP1074248A1
(en)
*
|
1999-07-08 |
2001-02-07 |
Arnold Hilgers |
Delivery system for biological material
|
ITMI991582A1
(it)
*
|
1999-07-16 |
2001-01-16 |
Chiesi Farma Spa |
Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
|
WO2001013891A2
(en)
*
|
1999-08-25 |
2001-03-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
US20010036481A1
(en)
*
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US6586008B1
(en)
*
|
1999-08-25 |
2003-07-01 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles during spray drying
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US7252840B1
(en)
|
1999-08-25 |
2007-08-07 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles
|
HU229310B1
(en)
|
1999-10-29 |
2013-10-28 |
Nektar Therapeutics |
Dry powder compositions having improved dispersivity
|
US7507687B2
(en)
*
|
2000-03-22 |
2009-03-24 |
Cabot Corporation |
Electrocatalyst powders, methods for producing powder and devices fabricated from same
|
US20030003057A1
(en)
*
|
2000-07-07 |
2003-01-02 |
Jeffry Weers |
Methods for administering leuprolide by inhalation
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
MXPA02001323A
(es)
*
|
2000-05-10 |
2004-07-16 |
Alliance Pharma |
Microgranulos con base fosfolipida para la liberacion de farmaco.
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US7575761B2
(en)
*
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
AU2001277230A1
(en)
*
|
2000-08-01 |
2002-02-13 |
Inhale Therapeutic Systems, Inc. |
Apparatus and process to produce particles having a narrow size distribution andparticles made thereby
|
JP2004515467A
(ja)
*
|
2000-08-07 |
2004-05-27 |
ネクター セラピューティックス |
吸入可能な、噴霧乾燥した、最少の凝集物を有する4−ヘリックスバンドルタンパク質粉末
|
JP2004523479A
(ja)
*
|
2000-10-18 |
2004-08-05 |
マサチューセッツ インスティテュート オブ テクノロジー |
多糖の肺送達に関する方法および産物
|
DE60138641D1
(de)
|
2000-10-27 |
2009-06-18 |
Baxter Healthcare Sa |
Herstellung von mikrokügelchen
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
CA2432175C
(en)
*
|
2000-12-21 |
2010-08-10 |
Jayne E. Hastedt |
Storage stable powder compositions of interleukin-4 receptor
|
US20020141946A1
(en)
*
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
US6887462B2
(en)
|
2001-04-09 |
2005-05-03 |
Chiron Corporation |
HSA-free formulations of interferon-beta
|
US6848197B2
(en)
*
|
2001-04-18 |
2005-02-01 |
Advanced Inhalation Research, Inc. |
Control of process humidity to produce large, porous particles
|
US20050143333A1
(en)
*
|
2001-05-18 |
2005-06-30 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)
|
US20060019913A1
(en)
*
|
2001-05-18 |
2006-01-26 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibtion of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)
|
US20040198682A1
(en)
*
|
2001-11-30 |
2004-10-07 |
Mcswiggen James |
RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA)
|
US20050256068A1
(en)
*
|
2001-05-18 |
2005-11-17 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)
|
US20050014172A1
(en)
*
|
2002-02-20 |
2005-01-20 |
Ivan Richards |
RNA interference mediated inhibition of muscarinic cholinergic receptor gene expression using short interfering nucleic acid (siNA)
|
US20050182007A1
(en)
*
|
2001-05-18 |
2005-08-18 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)
|
US20050287128A1
(en)
*
|
2001-05-18 |
2005-12-29 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA)
|
US20050233997A1
(en)
*
|
2001-05-18 |
2005-10-20 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)
|
US20050288242A1
(en)
*
|
2001-05-18 |
2005-12-29 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of RAS gene expression using short interfering nucleic acid (siNA)
|
US9994853B2
(en)
|
2001-05-18 |
2018-06-12 |
Sirna Therapeutics, Inc. |
Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
|
US20050148530A1
(en)
*
|
2002-02-20 |
2005-07-07 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
US20050187174A1
(en)
*
|
2001-05-18 |
2005-08-25 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
|
US20080161256A1
(en)
*
|
2001-05-18 |
2008-07-03 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
|
US20050159382A1
(en)
*
|
2001-05-18 |
2005-07-21 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)
|
US20050176666A1
(en)
*
|
2001-05-18 |
2005-08-11 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of GPRA and AAA1 gene expression using short interfering nucleic acid (siNA)
|
US20050233344A1
(en)
*
|
2001-05-18 |
2005-10-20 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)
|
US20050159376A1
(en)
*
|
2002-02-20 |
2005-07-21 |
Slrna Therapeutics, Inc. |
RNA interference mediated inhibition 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)
|
US20050282188A1
(en)
*
|
2001-05-18 |
2005-12-22 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
|
US20050267058A1
(en)
*
|
2001-05-18 |
2005-12-01 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (sINA)
|
US20050182009A1
(en)
*
|
2001-05-18 |
2005-08-18 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of NF-Kappa B / REL-A gene expression using short interfering nucleic acid (siNA)
|
US20050176664A1
(en)
*
|
2001-05-18 |
2005-08-11 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of cholinergic muscarinic receptor (CHRM3) gene expression using short interfering nucleic acid (siNA)
|
US20050119212A1
(en)
*
|
2001-05-18 |
2005-06-02 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of FAS and FASL gene expression using short interfering nucleic acid (siNA)
|
US20060241075A1
(en)
*
|
2001-05-18 |
2006-10-26 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of desmoglein gene expression using short interfering nucleic acid (siNA)
|
US20050054596A1
(en)
*
|
2001-11-30 |
2005-03-10 |
Mcswiggen James |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
US20050203040A1
(en)
*
|
2001-05-18 |
2005-09-15 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)
|
US20050222066A1
(en)
*
|
2001-05-18 |
2005-10-06 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
US20070042983A1
(en)
*
|
2001-05-18 |
2007-02-22 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
|
US20050159380A1
(en)
*
|
2001-05-18 |
2005-07-21 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of angiopoietin gene expression using short interfering nucleic acid (siNA)
|
US20050227935A1
(en)
*
|
2001-05-18 |
2005-10-13 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of TNF and TNF receptor gene expression using short interfering nucleic acid (siNA)
|
US20070270579A1
(en)
*
|
2001-05-18 |
2007-11-22 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
|
US20050164968A1
(en)
*
|
2001-05-18 |
2005-07-28 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of ADAM33 gene expression using short interfering nucleic acid (siNA)
|
US7517864B2
(en)
*
|
2001-05-18 |
2009-04-14 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
EP1270012A1
(en)
*
|
2001-06-21 |
2003-01-02 |
Pfizer Products Inc. |
Use of pulmonary administration of insulin for treatment of diabetes
|
US20050123509A1
(en)
*
|
2001-10-19 |
2005-06-09 |
Lehrman S. R. |
Modulating charge density to produce improvements in the characteristics of spray-dried proteins
|
AU2002335046A1
(en)
*
|
2001-10-19 |
2003-05-06 |
Inhale Therapeutic Systems, Inc. |
The use of proton sequestering agents in drug formulations
|
EP1992335A1
(en)
*
|
2001-11-01 |
2008-11-19 |
Nektar Therapeutics |
Spray drying methods and compositions thereof
|
WO2003043585A2
(en)
*
|
2001-11-20 |
2003-05-30 |
Advanced Inhalation Research, Inc. |
Improved particulate compositions for pulmonary delivery
|
US20030099601A1
(en)
*
|
2001-11-27 |
2003-05-29 |
Gordon Marc S. |
Inhalation lung surfactant therapy
|
US20070203333A1
(en)
*
|
2001-11-30 |
2007-08-30 |
Mcswiggen James |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
US20050075304A1
(en)
*
|
2001-11-30 |
2005-04-07 |
Mcswiggen James |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
US20040138163A1
(en)
*
|
2002-05-29 |
2004-07-15 |
Mcswiggen James |
RNA interference mediated inhibition of vascular edothelial growth factor and vascular edothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
US7368102B2
(en)
|
2001-12-19 |
2008-05-06 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
US20050042632A1
(en)
*
|
2002-02-13 |
2005-02-24 |
Sirna Therapeutics, Inc. |
Antibodies having specificity for nucleic acids
|
US9181551B2
(en)
|
2002-02-20 |
2015-11-10 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
US9657294B2
(en)
|
2002-02-20 |
2017-05-23 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
US20040014679A1
(en)
*
|
2002-02-20 |
2004-01-22 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
Inhalation powder containing the CGRP antagonist BIBN4096 and process for the preparation thereof
|
US20050137153A1
(en)
*
|
2002-02-20 |
2005-06-23 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of alpha-1 antitrypsin (AAT) gene expression using short interfering nucleic acid (siNA)
|
US20040063912A1
(en)
*
|
2002-03-15 |
2004-04-01 |
The Brigham And Women's Hospital, Inc. |
Central airway administration for systemic delivery of therapeutics
|
CN100343393C
(zh)
*
|
2002-03-15 |
2007-10-17 |
布赖汉姆妇女医院 |
适合治疗剂全身性递送的中央气道给药
|
DE60318938T2
(de)
|
2002-03-20 |
2009-01-22 |
Mannkind Corp., Valencia |
Inhalationsgerät
|
US20050163725A1
(en)
*
|
2002-03-20 |
2005-07-28 |
Blizzard Charles D. |
Method for administration of growth hormone via pulmonary delivery
|
US7008644B2
(en)
*
|
2002-03-20 |
2006-03-07 |
Advanced Inhalation Research, Inc. |
Method and apparatus for producing dry particles
|
WO2003079991A2
(en)
*
|
2002-03-20 |
2003-10-02 |
Advanced Inhalation Research, Inc. |
Method for administration of growth hormone via pulmonary delivery
|
KR20050011741A
(ko)
*
|
2002-04-11 |
2005-01-29 |
메드이뮨 백신즈 인코포레이티드 |
분무 건조에 의한 생물학적 활성 물질의 보존
|
GB0216562D0
(en)
*
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US20040087543A1
(en)
*
|
2002-04-25 |
2004-05-06 |
Zachary Shriver |
Methods and products for mucosal delivery
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
DE10234165B4
(de)
*
|
2002-07-26 |
2008-01-03 |
Advanced Micro Devices, Inc., Sunnyvale |
Verfahren zum Füllen eines Grabens, der in einem Substrat gebildet ist, mit einem isolierenden Material
|
EP1581639A4
(en)
*
|
2002-12-17 |
2006-03-08 |
Medimmune Vaccines Inc |
HIGH PRESSURE PULVISATION OF BIOACTIVE MATERIALS
|
WO2004057959A2
(en)
|
2002-12-20 |
2004-07-15 |
Generipharm, Inc. |
Intracutaneous injection
|
MXPA05007154A
(es)
*
|
2002-12-30 |
2005-09-21 |
Nektar Therapeutics |
Atomizador prepeliculizacion.
|
JP2006513235A
(ja)
*
|
2002-12-31 |
2006-04-20 |
ネクター セラピューティクス |
真菌感染症療法のためのエアゾール化可能な医薬製剤
|
EP1589947B2
(en)
*
|
2002-12-31 |
2019-01-30 |
Novartis AG |
Pharmaceutical formulation with an insoluble active agent for pulmonary administration
|
KR100500675B1
(ko)
*
|
2003-02-10 |
2005-07-11 |
주식회사 에이앤피사이언스 |
고유량 입자 분무장치
|
GB0304540D0
(en)
*
|
2003-02-27 |
2003-04-02 |
Elan Drug Delivery Ltd |
Particle formulation and its preparation
|
MXPA05012821A
(es)
*
|
2003-05-28 |
2006-02-13 |
Nektar Therapeutics |
Formulacion farmaceutica que comprende un agente activo insoluble en agua.
|
US20050014230A1
(en)
*
|
2003-07-16 |
2005-01-20 |
Ccl Holding Co., Ltd. |
Preparation of fully human antibodies
|
EP1581049B1
(en)
*
|
2003-07-28 |
2006-03-15 |
Pioneer Hi-Bred International, Inc. |
Apparatus, method, and system for applying substances to pre-harvested or harvested forage, grain, and crops
|
US20050042180A1
(en)
*
|
2003-08-18 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Powder formulation containing the CGRP antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2 (1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin, process for preparing and the use thereof as inhalation powder
|
US20050043247A1
(en)
*
|
2003-08-18 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative
|
US20050042179A1
(en)
*
|
2003-08-18 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine
|
US20050042178A1
(en)
*
|
2003-08-18 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder
|
GB0327723D0
(en)
*
|
2003-09-15 |
2003-12-31 |
Vectura Ltd |
Pharmaceutical compositions
|
WO2005032483A2
(en)
*
|
2003-10-01 |
2005-04-14 |
Momenta Pharmaceuticals, Inc. |
Polysaccharides for pulmonary delivery of active agents
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
WO2005044226A2
(en)
*
|
2003-11-04 |
2005-05-19 |
Nectar Therapeutics |
Lipid formulations for spontaneous drug encapsulation
|
KR20050056799A
(ko)
*
|
2003-12-10 |
2005-06-16 |
엘지.필립스 엘시디 주식회사 |
액정 표시패널의 실 패턴 구조
|
EP1701714A2
(en)
|
2004-01-07 |
2006-09-20 |
Nektar Therapeutics |
Improved sustained release compositions for pulmonary administration of insulin
|
CN101027082A
(zh)
*
|
2004-01-12 |
2007-08-29 |
曼恩坎德公司 |
降低2型糖尿病患者血清胰岛素原水平的方法
|
JP2007522246A
(ja)
*
|
2004-02-12 |
2007-08-09 |
ネクター セラピューティクス |
インターロイキン−13拮抗剤粉末剤、スプレードライ粒子、及び方法
|
ATE433746T1
(de)
*
|
2004-03-12 |
2009-07-15 |
Biodel Inc |
Insulinzusammensetzungen mit verbesserter wirkstoffabsorption
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
AU2005237523A1
(en)
*
|
2004-04-23 |
2005-11-10 |
Cydex Pharmaceuticals, Inc. |
DPI formulation containing sulfoalkyl ether cyclodextrin
|
US7727962B2
(en)
|
2004-05-10 |
2010-06-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder comprising new compositions of oligosaccharides and methods for their preparation
|
DE102004022926A1
(de)
*
|
2004-05-10 |
2005-12-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Sprühgetrocknete Pulver enthaltend zumindest ein 1,4 O-verknüpftes Saccharose-Derivat und Verfahren zu deren Herstellung
|
US7723306B2
(en)
|
2004-05-10 |
2010-05-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
|
DE102004022928A1
(de)
*
|
2004-05-10 |
2005-12-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulver enthaltend neuartige Oligosacharidgemische und Verfahren zu deren Herstellung
|
US7611709B2
(en)
|
2004-05-10 |
2009-11-03 |
Boehringer Ingelheim Pharma Gmbh And Co. Kg |
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
|
US10508277B2
(en)
|
2004-05-24 |
2019-12-17 |
Sirna Therapeutics, Inc. |
Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
|
US8513204B2
(en)
*
|
2004-06-21 |
2013-08-20 |
Novartis Ag |
Compositions comprising amphotericin B, mehods and systems
|
EP1773301A2
(en)
*
|
2004-06-21 |
2007-04-18 |
Nektar Therapeutics |
Compositions comprising amphotericinb methods and systems
|
EP2626368B1
(en)
|
2004-07-19 |
2016-12-21 |
Biocon Limited |
Insulin-oligomer conjugates, formulations and uses thereof
|
US20060024272A1
(en)
|
2004-07-29 |
2006-02-02 |
Large Scale Biology Corporation |
C-terminally truncated interferon
|
EP1786784B1
(en)
|
2004-08-20 |
2010-10-27 |
MannKind Corporation |
Catalysis of diketopiperazine synthesis
|
CA2578175C
(en)
|
2004-08-23 |
2014-10-14 |
Mannkind Corporation |
Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
|
SE0402345L
(sv)
*
|
2004-09-24 |
2006-03-25 |
Mederio Ag |
Uppmätt läkemedelsdos
|
US9149433B2
(en)
*
|
2004-11-30 |
2015-10-06 |
Basf Corporation |
Method for formation of micro-prilled polymers
|
WO2006060792A2
(en)
*
|
2004-11-30 |
2006-06-08 |
The Administrators Of The Tulane Educational Fund |
Nebulizing treatment method
|
WO2006076097A2
(en)
*
|
2004-12-07 |
2006-07-20 |
Nektar Therapeutics |
Stable non-crystalline formulation comprising losartan
|
US20080213593A1
(en)
*
|
2005-01-21 |
2008-09-04 |
President And Fellows Of Harvard College |
Systems And Methods For Forming Fluidic Droplets Encapsulated In Particles Such As Colloidal Particles
|
US20090053314A1
(en)
*
|
2005-03-22 |
2009-02-26 |
Regeron, Inc. |
Submicronization of proteins using supercritical fluids
|
JP5087539B2
(ja)
|
2005-05-18 |
2012-12-05 |
ネクター セラピューティックス |
気管支内治療のためのバルブ、デバイス、および方法
|
WO2007019554A2
(en)
*
|
2005-08-08 |
2007-02-15 |
Momenta Pharmaceuticals, Inc. |
Polysaccharides for delivery of active agents
|
US7803404B2
(en)
|
2005-09-14 |
2010-09-28 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
|
WO2007041481A1
(en)
*
|
2005-09-29 |
2007-04-12 |
Biodel, Inc. |
Rapid acting and prolonged acting insulin preparations
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
EP2364735A3
(en)
|
2005-12-16 |
2012-04-11 |
Nektar Therapeutics |
Branched PEG conjugates of GLP-1
|
US9012605B2
(en)
|
2006-01-23 |
2015-04-21 |
Amgen Inc. |
Crystalline polypeptides
|
KR102180849B1
(ko)
*
|
2006-01-24 |
2020-11-20 |
안선 바이오파르마, 아이엔씨. |
고분자 미소 구체들의 조제를 위한 기술
|
GB0602897D0
(en)
*
|
2006-02-13 |
2006-03-22 |
Jagotec Ag |
Improvements In Or Relating To Dry Powder Inhaler Devices
|
BRPI0707991B8
(pt)
|
2006-02-22 |
2021-05-25 |
Mannkind Corp |
métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
|
CA2649109A1
(en)
*
|
2006-04-12 |
2007-10-25 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
DK2080408T3
(da)
|
2006-10-23 |
2012-11-19 |
Starkey Lab Inc |
Undgåelse af medrivning med et auto-regressivt filter
|
GB0622818D0
(en)
*
|
2006-11-15 |
2006-12-27 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
GB0625303D0
(en)
*
|
2006-12-19 |
2007-01-24 |
Jagotec Ag |
Improvements in and relating to metered dose inhalers
|
US7985058B2
(en)
*
|
2007-01-12 |
2011-07-26 |
Mark Gray |
Method and apparatus for making uniformly sized particles
|
US8747872B2
(en)
*
|
2007-05-02 |
2014-06-10 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
WO2009045553A1
(en)
|
2007-10-05 |
2009-04-09 |
Barofold, Inc. |
High pressure treatment of aggregated interferons
|
CA2991162A1
(en)
*
|
2007-12-21 |
2009-07-02 |
Aptevo Biotherapeutics Llc |
Stabilized factor ix formulations containing trehalose
|
EP2077132A1
(en)
|
2008-01-02 |
2009-07-08 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
AU2009204309B2
(en)
*
|
2008-01-04 |
2012-11-22 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
US8986253B2
(en)
|
2008-01-25 |
2015-03-24 |
Tandem Diabetes Care, Inc. |
Two chamber pumps and related methods
|
BRPI0913021A2
(pt)
*
|
2008-05-15 |
2015-10-13 |
Novartis Ag |
distribuição pulmonar de uma fluoroquinolona
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
EP2570147B1
(en)
|
2008-06-13 |
2017-10-18 |
MannKind Corporation |
A dry powder inhaler and system for drug delivery
|
US9364619B2
(en)
|
2008-06-20 |
2016-06-14 |
Mannkind Corporation |
Interactive apparatus and method for real-time profiling of inhalation efforts
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
US8408421B2
(en)
|
2008-09-16 |
2013-04-02 |
Tandem Diabetes Care, Inc. |
Flow regulating stopcocks and related methods
|
WO2010033207A1
(en)
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Polymer conjugates of therapeutic peptides
|
CA2737461A1
(en)
|
2008-09-19 |
2010-03-25 |
Tandem Diabetes Care, Inc. |
Solute concentration measurement device and related methods
|
EP2349209A2
(en)
*
|
2008-09-26 |
2011-08-03 |
Nanobio Corporation |
Nanoemulsion therapeutic compositions and methods of using the same
|
US8293221B2
(en)
|
2008-10-03 |
2012-10-23 |
E. I. Du Pont De Nemours And Company |
Enzymatic peracid generation formulation
|
CA2743904A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
US9827205B2
(en)
*
|
2008-12-12 |
2017-11-28 |
Mallinckrodt Pharma Ip Trading D.A.C. |
Dry powder fibrin sealant
|
WO2010078373A1
(en)
|
2008-12-29 |
2010-07-08 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
EP2401587A2
(en)
|
2009-02-27 |
2012-01-04 |
Tandem Diabetes Care, Inc. |
Methods and devices for determination of flow reservoir volume
|
US9250106B2
(en)
|
2009-02-27 |
2016-02-02 |
Tandem Diabetes Care, Inc. |
Methods and devices for determination of flow reservoir volume
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
PL2405963T3
(pl)
|
2009-03-11 |
2014-04-30 |
Mannkind Corp |
Urządzenie, układ i sposób pomiaru oporu inhalatora
|
EP3552603A1
(en)
|
2009-03-18 |
2019-10-16 |
Incarda Therapeutics, Inc. |
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
|
JP2012520686A
(ja)
|
2009-03-19 |
2012-09-10 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸(siNA)を用いたシグナル伝達性転写因子6(STAT6)遺伝子発現のRNA干渉媒介性阻害
|
CN102439151A
(zh)
|
2009-03-19 |
2012-05-02 |
默沙东公司 |
使用短干扰核酸(siNA)的RNA干扰介导的BTB和CNC同系物1,碱性亮氨酸拉链转录因子1(Bach1)基因表达的抑制
|
JP2012520683A
(ja)
|
2009-03-19 |
2012-09-10 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸(siNA)を用いた結合組織増殖因子(CTGF)遺伝子発現のRNA干渉媒介性阻害
|
WO2010107957A2
(en)
|
2009-03-19 |
2010-09-23 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
WO2010111471A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
EP2411018A2
(en)
|
2009-03-27 |
2012-02-01 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
|
SG174581A1
(en)
|
2009-03-27 |
2011-10-28 |
Merck Sharp & Dohme |
RNA INTERFERENCE MEDIATED INHIBITION OF THE INTERCELLULAR ADHESION MOLECULE 1 (ICAM-1)GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
JP2012521764A
(ja)
|
2009-03-27 |
2012-09-20 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸(siNA)を用いた胸腺間質性リンパ球新生因子(TSLP)遺伝子発現のRNA干渉媒介性阻害
|
WO2010111464A1
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
US10011906B2
(en)
|
2009-03-31 |
2018-07-03 |
Beohringer Ingelheim International Gmbh |
Method for coating a surface of a component
|
EP2413903A4
(en)
|
2009-04-01 |
2013-01-02 |
Promedior Inc |
PULMONARY AND NASAL ADMINISTRATION OF AMYLOID P SERUM SUBSTANCE
|
EP3508239B1
(de)
|
2009-05-18 |
2020-12-23 |
Boehringer Ingelheim International GmbH |
Adapter, inhalationseinrichtung und zerstäuber
|
CA2764759A1
(en)
|
2009-06-09 |
2010-12-16 |
Defyrus, Inc. |
Administration of interferon for prophylaxis against or treatment of pathogenic infection
|
KR20180079458A
(ko)
|
2009-06-12 |
2018-07-10 |
맨카인드 코포레이션 |
한정된 비표면적을 갖는 디케토피페라진 마이크로입자
|
US20110152770A1
(en)
|
2009-07-30 |
2011-06-23 |
Tandem Diabetes Care, Inc. |
Infusion pump system with disposable cartridge having pressure venting and pressure feedback
|
US8222012B2
(en)
|
2009-10-01 |
2012-07-17 |
E. I. Du Pont De Nemours And Company |
Perhydrolase for enzymatic peracid production
|
RU2555332C2
(ru)
*
|
2009-11-03 |
2015-07-10 |
Грифольс Терапьютикс Инк. |
Композиция, способ и набор для альфа-1 ингибитора протеазы
|
EP2496295A1
(en)
|
2009-11-03 |
2012-09-12 |
MannKind Corporation |
An apparatus and method for simulating inhalation efforts
|
EP2504051B1
(en)
|
2009-11-25 |
2019-09-04 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
US10016568B2
(en)
|
2009-11-25 |
2018-07-10 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
WO2011064164A1
(en)
|
2009-11-25 |
2011-06-03 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
EP2330094B1
(en)
*
|
2009-12-03 |
2017-02-08 |
PURAC Biochem BV |
Alkali metal cinnamate powder and method for preparation
|
AU2010328104B2
(en)
|
2009-12-09 |
2014-10-30 |
Nitto Denko Corporation |
Modulation of hsp47 expression
|
CN101816913B
(zh)
*
|
2010-05-20 |
2015-10-21 |
吴传斌 |
一种微球制造方法及制造设备
|
RU2531455C2
(ru)
|
2010-06-21 |
2014-10-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
WO2011160932A1
(en)
|
2010-06-24 |
2011-12-29 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
WO2012012460A1
(en)
|
2010-07-19 |
2012-01-26 |
Xeris Pharmaceuticals, Inc. |
Stable glucagon formulations for the treatment of hypoglycemia
|
KR20170084354A
(ko)
|
2010-09-24 |
2017-07-19 |
유니버시티 오브 플로리다 리서치 파운데이션, 인크. |
위장 기능을 증진시키기 위한 물질 및 방법
|
WO2012058210A1
(en)
|
2010-10-29 |
2012-05-03 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)
|
CN103429228B
(zh)
|
2011-01-05 |
2016-10-26 |
赫士睿股份有限公司 |
万古霉素的喷雾干燥
|
AU2012215514B2
(en)
*
|
2011-02-10 |
2017-04-20 |
Janssen Vaccines & Prevention B.V. |
Pneumatic alternating pressure membrane cell separation system
|
US9808030B2
(en)
|
2011-02-11 |
2017-11-07 |
Grain Processing Corporation |
Salt composition
|
US8708159B2
(en)
*
|
2011-02-16 |
2014-04-29 |
Oakwood Laboratories, Llc |
Manufacture of microspheres using a hydrocyclone
|
RU2603610C2
(ru)
|
2011-02-25 |
2016-11-27 |
Конинклейке Филипс Электроникс Н.В. |
Устройство для генерирования аэрозоля для распыления жидкости, и способ управления температурой распыляемой жидкости
|
WO2012118910A2
(en)
|
2011-03-03 |
2012-09-07 |
Quark Pharmaceuticals, Inc. |
Compositions and methods for treating lung disease and injury
|
EP3225235B1
(en)
|
2011-03-10 |
2020-12-16 |
Xeris Pharmaceuticals, Inc. |
Stable peptide formulations for parenteral injection
|
EA028572B1
(ru)
|
2011-03-10 |
2017-12-29 |
Ксерис Фармасьютикалс, Инк. |
Стабильная композиция для парентеральной инъекции и способы ее получения и использования
|
EP2694220B1
(de)
|
2011-04-01 |
2020-05-06 |
Boehringer Ingelheim International GmbH |
Medizinisches gerät mit behälter
|
CN105667994B
(zh)
|
2011-04-01 |
2018-04-06 |
曼金德公司 |
用于药物药盒的泡罩包装
|
US9572774B2
(en)
|
2011-05-19 |
2017-02-21 |
Savara Inc. |
Dry powder vancomycin compositions and associated methods
|
MX346244B
(es)
*
|
2011-05-19 |
2017-03-13 |
Savara Inc |
Composiciones de vancomicina en polvo seco y metodos asociados.
|
US9827384B2
(en)
|
2011-05-23 |
2017-11-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
US10196637B2
(en)
|
2011-06-08 |
2019-02-05 |
Nitto Denko Corporation |
Retinoid-lipid drug carrier
|
RS59380B1
(sr)
|
2011-06-08 |
2019-11-29 |
Nitto Denko Corp |
Jedinjenja za ciljanje isporuke leka i pojačavanje sirnk aktivnosti
|
TWI658830B
(zh)
|
2011-06-08 |
2019-05-11 |
日東電工股份有限公司 |
Hsp47表現調控強化用類視色素脂質體
|
US9011903B2
(en)
|
2011-06-08 |
2015-04-21 |
Nitto Denko Corporation |
Cationic lipids for therapeutic agent delivery formulations
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
AU2012328885B2
(en)
|
2011-10-24 |
2017-08-31 |
Mannkind Corporation |
Methods and compositions for treating pain
|
KR102276161B1
(ko)
|
2011-10-25 |
2021-07-14 |
프로테나 바이오사이언시즈 리미티드 |
항체 제형 및 방법
|
AU2012332556B2
(en)
|
2011-10-31 |
2016-05-26 |
Xeris Pharmaceuticals, Inc. |
Formulations for the treatment of diabetes
|
US9643996B2
(en)
*
|
2011-11-04 |
2017-05-09 |
Battelle Memorial Institute |
Processes for producing protein microparticles
|
EP2601941A1
(en)
|
2011-12-06 |
2013-06-12 |
Ludwig-Maximilians-Universität München |
Beta-O/S/N fatty acid based compounds as antibacterial and antiprotozoal agents
|
AU2012351947B2
(en)
|
2011-12-16 |
2017-08-17 |
Novartis Ag |
Aerosolization apparatus for inhalation profile-independent drug delivery
|
EP2809780B1
(en)
|
2012-02-01 |
2018-05-02 |
Protalix Ltd. |
Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
|
ES2691083T3
(es)
|
2012-04-05 |
2018-11-23 |
University Of Florida Research Foundation, Inc. |
Composición para el tratamiento de fibrosis quística y la inducción de secreción de iones
|
US8753643B1
(en)
|
2012-04-11 |
2014-06-17 |
Life-Science Innovations, Llc |
Spray dried compositions and methods of use
|
KR20140147891A
(ko)
|
2012-04-13 |
2014-12-30 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
응집체 입자
|
WO2013152894A1
(de)
|
2012-04-13 |
2013-10-17 |
Boehringer Ingelheim International Gmbh |
Zerstäuber mit kodiermitteln
|
US9180242B2
(en)
|
2012-05-17 |
2015-11-10 |
Tandem Diabetes Care, Inc. |
Methods and devices for multiple fluid transfer
|
US9555186B2
(en)
|
2012-06-05 |
2017-01-31 |
Tandem Diabetes Care, Inc. |
Infusion pump system with disposable cartridge having pressure venting and pressure feedback
|
US9125805B2
(en)
|
2012-06-27 |
2015-09-08 |
Xeris Pharmaceuticals, Inc. |
Stable formulations for parenteral injection of small molecule drugs
|
US20140099380A1
(en)
|
2012-06-28 |
2014-04-10 |
Ansun Biopharma, Inc. |
Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture
|
CN108057154B
(zh)
|
2012-07-12 |
2021-04-16 |
曼金德公司 |
干粉药物输送系统和方法
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
US9018162B2
(en)
|
2013-02-06 |
2015-04-28 |
Xeris Pharmaceuticals, Inc. |
Methods for rapidly treating severe hypoglycemia
|
WO2014124096A1
(en)
|
2013-02-06 |
2014-08-14 |
Perosphere Inc. |
Stable glucagon formulations
|
MX361647B
(es)
|
2013-03-11 |
2018-12-13 |
Univ Florida |
Materiales y métodos para mejorar la función pulmonar y para la prevención y/o tratamiento de complicaciones pulmonares inducidas por radiación.
|
US9173998B2
(en)
|
2013-03-14 |
2015-11-03 |
Tandem Diabetes Care, Inc. |
System and method for detecting occlusions in an infusion pump
|
CA2906817C
(en)
|
2013-03-15 |
2022-01-18 |
Mannkind Corporation |
Microcrystalline diketopiperazine compositions and methods
|
CN104043104B
(zh)
|
2013-03-15 |
2018-07-10 |
浙江创新生物有限公司 |
含盐酸万古霉素的喷雾干粉及其工业化制备方法
|
EP3607941A1
(en)
|
2013-04-30 |
2020-02-12 |
Otitopic Inc. |
Dry powder formulations and methods of use
|
WO2014207213A1
(en)
|
2013-06-28 |
2014-12-31 |
Medizinische Universität Innsbruck |
Novel inhibitors of protein kinase c epsilon signaling
|
US9925144B2
(en)
|
2013-07-18 |
2018-03-27 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
JP2016530930A
(ja)
|
2013-08-05 |
2016-10-06 |
マンカインド コーポレイション |
通気装置及び方法
|
EP3030298B1
(en)
|
2013-08-09 |
2017-10-11 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
EP2835146B1
(en)
|
2013-08-09 |
2020-09-30 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
PL3107548T3
(pl)
|
2014-02-20 |
2022-10-31 |
Otitopic Inc. |
Suche formulacje w proszku do inhalacji
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
EA032459B1
(ru)
|
2014-05-07 |
2019-05-31 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Небулайзер
|
PL3139979T3
(pl)
|
2014-05-07 |
2023-12-27 |
Boehringer Ingelheim International Gmbh |
Jednostka, nebulizator i sposób
|
US10722666B2
(en)
|
2014-05-07 |
2020-07-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer with axially movable and lockable container and indicator
|
EP2947460A1
(en)
|
2014-05-22 |
2015-11-25 |
Medizinische Universität Wien |
Personalized therapy of inflammation-associated cancer using methods of assessing the susceptibility of a subject to the treatment with EGFR inhibitors/antagonists
|
DK3166595T3
(da)
|
2014-07-08 |
2019-08-05 |
Amphastar Pharmaceuticals Inc |
Mikroniseret insulin, mikroniserede insulinanaloger, og fremgangsmåder til fremstilling deraf
|
JP6982495B2
(ja)
|
2014-08-06 |
2021-12-17 |
ゼリス ファーマシューティカルズ インコーポレイテッド |
ペーストの皮内および/または皮下注射のためのシリンジ、キット、および方法
|
US10575417B2
(en)
|
2014-09-08 |
2020-02-25 |
The Stanley Works Israel Ltd. |
Jobsite communications center
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
EP4112076A1
(en)
|
2014-10-10 |
2023-01-04 |
The Regents of The University of Michigan |
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
|
US20170304459A1
(en)
|
2014-10-10 |
2017-10-26 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
WO2016067252A1
(en)
|
2014-10-31 |
2016-05-06 |
Glaxosmithkline Intellectual Property Development Limited |
Powder formulation
|
EP3616689A1
(en)
|
2014-11-24 |
2020-03-04 |
Entrinsic Health Solutions, Inc. |
Amino acid compositions for the treatment of symptoms of disease
|
AU2016204793B2
(en)
|
2015-01-04 |
2021-12-16 |
Protalix Ltd. |
Modified DNase and uses thereof
|
WO2016135138A1
(en)
|
2015-02-23 |
2016-09-01 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
Oxoquinoline derivatives as mth1 inhibitors for the therapy of cancer
|
WO2016135139A1
(en)
|
2015-02-23 |
2016-09-01 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
2,3-dihydrocyclopenta[b]quinoline derivatives as mth1 inhibitors for the therapy of cancer
|
WO2016135140A1
(en)
|
2015-02-23 |
2016-09-01 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
4-aminoquinazoline derivatives as mth1 inhibitors for the therapy of cancer
|
WO2016135137A1
(en)
|
2015-02-23 |
2016-09-01 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
Substituted 4-(phenylamino)quinoline derivatives as mth1 inhibitors for the therapy of cancer
|
US10864190B2
(en)
|
2015-04-22 |
2020-12-15 |
CeMM—FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GmbH |
Combination of an antiandrogen with a vitamin K antagonist or with a gamma-glutamyl carboxylase inhibitor for the therapy of androgen receptor positive cancer
|
CN108686286A
(zh)
*
|
2015-05-16 |
2018-10-23 |
苏州汉方医药有限公司 |
由手动悬浮微颗粒发生器和复方党参组成的药盒
|
US9649364B2
(en)
|
2015-09-25 |
2017-05-16 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic formulations in aprotic polar solvents
|
WO2016196976A1
(en)
|
2015-06-04 |
2016-12-08 |
Xeris Pharmaceuticals, Inc. |
Glucagon delivery apparatuses and related methods
|
WO2016201248A1
(en)
|
2015-06-10 |
2016-12-15 |
Xeris Pharmaceuticals, Inc. |
Use of low dose glucagon
|
US11590205B2
(en)
|
2015-09-25 |
2023-02-28 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
|
PL3386997T3
(pl)
|
2015-12-09 |
2021-12-13 |
Medizinische Universität Wien |
Funkcjonalizowane monomaleimidem związki platyny do terapii nowotworowej
|
CN106968984B
(zh)
*
|
2015-12-11 |
2020-10-23 |
松下知识产权经营株式会社 |
涡轮机
|
US10322168B2
(en)
|
2016-01-07 |
2019-06-18 |
Amphastar Pharmaceuticals, Inc. |
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
|
CN109071482A
(zh)
|
2016-01-15 |
2018-12-21 |
汉堡大学 |
携有o-鼠李糖基残基的类黄酮型化合物
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
US10328216B2
(en)
|
2016-01-20 |
2019-06-25 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispensible spray dried powders suitable for inhalation
|
EP3411030A4
(en)
|
2016-02-01 |
2019-09-04 |
InCarda Therapeutics, Inc. |
COMBINING ELECTRONIC SURVEILLANCE WITH INHALATION PHARMACOLOGICAL THERAPY FOR MANAGING CARDIAC ARRHYTHMIAS WITH ATRIAL FIBRILLATION
|
WO2017140728A1
(en)
|
2016-02-15 |
2017-08-24 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
Taf1 inhibitors for the therapy of cancer
|
US20190111069A1
(en)
|
2016-04-15 |
2019-04-18 |
Oxford University Innovation Limited |
Adenosine Receptor Modulators for the Treatment of Circadian Rhythm Disorders
|
US10704425B2
(en)
*
|
2016-07-14 |
2020-07-07 |
General Electric Company |
Assembly for a gas turbine engine
|
CA3039514C
(en)
|
2016-10-04 |
2022-01-25 |
University Of Florida Research Foundation, Incorporated |
Amino acid compositions and uses thereof
|
EP3538100A2
(en)
|
2016-11-14 |
2019-09-18 |
CeMM - Forschungszentrum für Molekulare Medizin GmbH |
Combination of a brd4 inhibitor and an antifolate for the therapy of cancer
|
EP3621616A4
(en)
|
2017-05-10 |
2021-01-13 |
InCarda Therapeutics, Inc. |
UNIT DOSE, AEROSOLS, KITS AND METHODS FOR TREATMENT OF HEART DISEASE BY PULMONAL ADMINISTRATION
|
JP7210476B2
(ja)
|
2017-05-22 |
2023-01-23 |
インスメッド インコーポレイテッド |
リポ‐グリコペプチド可切断性誘導体及びその使用
|
EP4378463A2
(en)
|
2017-06-02 |
2024-06-05 |
Xeris Pharmaceuticals, Inc. |
Precipitation resistant small molecule drug formulations
|
EP3655021B1
(en)
|
2017-07-19 |
2023-03-22 |
Unikeris Limited |
Adenosine deaminase for treating or ameliorating scleroderma-associated vasculopathy
|
US20210179591A1
(en)
|
2017-12-05 |
2021-06-17 |
Eth Zurich |
New compounds for use as a therapeutically active substance and in particular for use in the treatment of tumors
|
WO2019183470A2
(en)
|
2018-03-22 |
2019-09-26 |
Incarda Therapeutics, Inc. |
A novel method to slow ventricular rate
|
AU2019247641A1
(en)
|
2018-04-06 |
2020-11-12 |
Zilentin AG |
Bumetanide derivatives for the therapy of hyperhidrosis
|
WO2019193161A1
(en)
|
2018-04-06 |
2019-10-10 |
Universität Wien |
Bumetanide derivatives for the therapy of stroke and other neurological diseases/disorders involving nkccs
|
DK3599243T3
(da)
|
2018-07-26 |
2023-07-10 |
Cvie Therapeutics Ltd |
17beta-heterocyklyl-digitalis-lignende forbindelser til behandlingen af hjertesvigt
|
WO2020127200A1
(en)
|
2018-12-17 |
2020-06-25 |
Tolremo Therapeutics Ag |
Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of cancer
|
MX2021013329A
(es)
|
2019-04-29 |
2022-03-17 |
Insmed Inc |
Composiciones de polvo seco de los profarmacos de treprostinil y métodos de uso de las mismas.
|
RU193395U1
(ru)
*
|
2019-06-17 |
2019-10-28 |
Евгений Викторович Крейдин |
Генератор сухого солевого аэрозоля
|
US11007185B2
(en)
|
2019-08-01 |
2021-05-18 |
Incarda Therapeutics, Inc. |
Antiarrhythmic formulation
|
WO2021064141A1
(en)
|
2019-10-02 |
2021-04-08 |
Tolremo Therapeutics Ag |
Inhibitors of dual specificity tyrosine phosphorylation regulated kinase 1b
|
EP4041399A1
(en)
|
2019-10-02 |
2022-08-17 |
Tolremo Therapeutics AG |
Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer
|
PL3805243T3
(pl)
|
2019-10-09 |
2024-03-18 |
Windtree Therapeutics, Inc. |
Pochodne androstanowe posiadające aktywność jako czyste lub w przeważającym stopniu czyste stymulatory SERCA2A do leczenia niewydolności serca
|
EP4045142A1
(en)
|
2019-10-16 |
2022-08-24 |
CeMM - Forschungszentrum für Molekulare Medizin GmbH |
Oxazole and thioazole-type cullin ring ubiquitin ligase compounds and uses thereof
|
WO2021074418A1
(en)
|
2019-10-16 |
2021-04-22 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
Carbazole-type cullin ring ubiquitin ligase compounds and uses thereof
|
US20230158125A1
(en)
|
2020-04-20 |
2023-05-25 |
Sorrento Therapeutics, Inc. |
Pulmonary Administration of ACE2 Polypeptides
|
US20230226057A1
(en)
|
2020-06-25 |
2023-07-20 |
Tolremo Therapeutics Ag |
Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of fibrotic disease
|
EP3939578A1
(en)
|
2020-07-13 |
2022-01-19 |
Novaremed Ltd. |
Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease
|
EP3964497A1
(en)
|
2020-09-04 |
2022-03-09 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Substituted vicinal diamine compounds and their use in the treatment, amelioration or prevention of pain
|
US20230416707A1
(en)
|
2020-10-07 |
2023-12-28 |
Protalix Ltd. |
Long-acting dnase
|
JP2023545588A
(ja)
|
2020-10-16 |
2023-10-30 |
ツェーエムエム-フォルシュングスツェントルム フュア モレクラレ メディツィン ゲーエムベーハー |
ヘテロ環式カリンringユビキチンリガーゼ化合物及びその使用
|
KR20230167092A
(ko)
|
2021-04-07 |
2023-12-07 |
톨레모 테라퓨틱스 아게 |
헤테로사이클릭 유도체, 약학 조성물, 및 암의 치료 또는 개선에서의 그들의 용도
|
WO2023150747A1
(en)
|
2022-02-07 |
2023-08-10 |
Insmed Incorporated |
Dry powder compositions of bedaquiline and salts and methods of use thereof
|
WO2023203172A1
(en)
|
2022-04-20 |
2023-10-26 |
Proxygen Gmbh |
Heterocyclic cullin ring ubiquitin ligase compounds and uses thereof
|